Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,276,438
-$99,747,786 QoQ
Shares Held
45,954
-97.1% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. ACLX ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in ACLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,276,438 | 45,954 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $105,024,224 | 1,610,801 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $103,778,586 | 1,264,051 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $94,743,202 | 1,438,773 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $120,679,334 | 1,839,624 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $162,684,183 | 2,121,322 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $158,720,024 | 1,900,611 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $89,997,780 | 1,630,690 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $93,513,660 | 1,344,553 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $69,939,989 | 1,260,180 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $33,614,931 | 936,871 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,447,034 | 1,057,781 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $684,752 | 22,225 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,895,669 | 93,469 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||